Navigation Links
RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
Date:2/8/2013

SEOUL, South Korea, Feb. 8, 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem™ stem cell drug in patients with cerebral palsy. The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months.  The study is to be conducted through Kyung Hee University Hospital at Gangdong and THE Bethesda Hospital.

RNL-Astrostem™, has already completed a phase I trial to assure safety, including tests to rule out toxicity or tumorigenicity.  This trial was conducted at the Seoul National University's Clinical Research Institute.  In addition, the phase I study has confirmed the safety of stem cells infused by IV, as published in a leading peer-reviewed journal, Stem Cells and Development ("Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans," February 2011). In the course of successful safety trials, scientists found significant evidence suggesting the potential for efficacy of stem cells in treatment of cerebral palsy. In addition, a case report with obvious result of improvement was published in another internationally renowned journal. RNL BIO believes that with successful trials and approval of the KFDA, it will be possible to commercialize RNL-Astrostem™ by 2014, revolutionizing the possibility to cure this incurable disease of children, which can only be managed with current technologies.

Cerebral Palsy is caused by non-progressive brain damage from single or multiple defect(s) on the nerve/muscular system and results in disorder in motion and sensory integration. According to Health Insurance Review and Assessment Service, the prevalence of cerebral palsy is 3.5 pe
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... JOSE, Calif. , Nov. 26, 2014 /PRNewswire/ ... technologies to produce novel therapies for infectious diseases, ... , M.D., an internationally recognized key opinion leader ... the Company,s scientific advisory board. Founder ... Ph.D., stated, "We believe Dr. Opal,s extensive experience ...
(Date:11/26/2014)... 2014 According to the ... Source (Electric, Battery, Pneumatic), by Product (Drill, Saw, ... by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - ... Powered Surgical Instruments Market is estimated to be ... and is expected to grow at a moderate ...
(Date:11/26/2014)... Reinforcing its commitment to enabling confident diagnosis ... PHG AEX: PHIA) today announced 510(k) clearance from ... IQon Spectral CT , presenting an entirely new ... a new dimension to Computed Tomography (CT) imaging, delivering ... based on their material content within a single scan. ...
Breaking Medicine Technology:Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... FRANCISCO, April 4, 2008 VIA,Pharmaceuticals (Nasdaq: ... of compounds for the treatment of cardiovascular disease,announced ... (DSMB),for its VIA-2291 Phase 2 clinical trial program ... Phase 2 studies. The DSMB observed a,continued acceptable ...
... Initiative Provides Broader Access to FOSRENOL(R) and Resources ... for Enhanced Hyperphosphatemia Management, ... company, today announced the launch of On Track,an innovative ... chronic kidney disease (CKD) Stage 5 patients with,hyperphosphatemia (elevated ...
Cached Medicine Technology:VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8
(Date:11/27/2014)... Providenciales, Turks and Caicos Islands; BWI (PRWEB) November 28, ... earlier for the Tuscany Resort in the Turks & ... 44 resorts by TripAdvisor in Providenciales, is announcing a ... oceanfront three bedroom villa rentals. And they are ... the resort. , Additionally, The Tuscany, is having ...
(Date:11/27/2014)... 28, 2014 Let the Black Friday sales ... with bows on top, filled with skincare goodies, will delight ... discounted today while quantities last - no coupon required. ... are also available on Amazon at the same sales prices. ... shop product page for ease. , The company published a ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 According to ... those companies looking to break into the surgical ... medical specialties, other than the MIS field dominated by ... of the U.S. surgical robotics market by 2020. ... explains Dr. Kamran Zamanian, CEO and President of iData. ...
(Date:11/27/2014)... Cambrionix Ltd today announced that it ranked number ... of the 50 fastest-growing technology companies in the UK. ... five years. Cambrionix Ltd grew 2989 percent during this ... region of Cambridgeshire and East and first in the sector ... is recognition of the hard work put in by our ...
(Date:11/27/2014)... Blood-borne pathogens raise the risk of spreading ... in place to counter this. However, it doesn’t seem ... with menstrual blood are taken as seriously. , ... way to handle tampons and menstrual pads while also ... , He then created a prototype of the Sani-M, ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay, Top-Rated TripAdvisor Resort in the Turks & Caicos Islands, Offers Special Pre-Christmas & January 2015 Promotions! 2Health News:Big Christmas Sales Begin Today at Sublime Beauty® for all Christmas Gift Selections and Skincare Sets 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 2Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 3Health News:Cambrionix Ltd Ranks Top 10 in the Deloitte UK Technology Fast 50 4
... , , , ... (Nasdaq: ROCM ) today announced the introduction of ... line features proprietary comfort layered technology. The company,s StrataSI(TM) ... anti-infective matrix within the silicone. , , ...
... 3 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB: ALRX), an ... develop novel formulations of drugs, today announced that it ... Rodman Renshaw Annual Global Investment Conference at ... conference will be held at the New York Palace ...
... ATLANTA, Sept. 3 Deborah Powers of Cerjo-USA, ... http://www.cerjoUSA.com , will be supporting the fundraising efforts ... Robins in 1979. The Skin Cancer Foundation provides life-saving ... every year. The Foundation provides wide-ranging skin cancer prevention ...
... injuries, watch backpack weight and fit, expert suggests, , THURSDAY, ... great help to school children, but it needs to fit ... , "If too heavy or worn incorrectly, backpacks can ... Kramer, who chairs the occupational therapy department at the University ...
... Briefing is the first in a three-part series ... WASHINGTON, Sept. 3 The following is being released by the ... http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO ) , , ... breakfast briefing on Capitol Hill titled "Education and Immigration: The Building ...
... , WYCKOFF, N.J., Sept. 3 ... support formula combining five highly researched ingredients shown specifically to ... , , According to Gerald Bruno, ... unique in its combination, but affords customers an economically friendly ...
Cached Medicine News:Health News:Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters 2Health News:Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters 3Health News:ALPHARx to Present at Rodman Renshaw Annual Global Investment Conference 2Health News:Skin Cancer Worrying You? Us too, Which Is Why Cerjo-USA Is Helping the Skin Cancer Foundation 2Health News:Skin Cancer Worrying You? Us too, Which Is Why Cerjo-USA Is Helping the Skin Cancer Foundation 3Health News:Take the Load Off Your Child's Back 2Health News:Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration: The Building Blocks of Innovation 2Health News:The Power of Five: New OmniFlex Nourishes Joints in Convenient, Effective Doses 2
96 channel Parallel dispenser using Positive Air Displacement Technology...
The WP1000S is a shortened base version of the WellPro that is shortened 5 inches to facilitate fitting into smaller biohazard hoods....
... Wellpro 384, compatible ... automated liquid handling system ... quickly and accurately prepares ... dilutions. The Wellpro ...
... series of robotic workstations is designed for ... is the ideal automation platform for routine ... laboratory procedures, improving throughput, process consistency and ... MiniPrep software allows you to control the ...
Medicine Products: